Masimo's Rainbow SET measures hemoglobin, oxygen content, carboxyhemoglobin and methemoglobin.
January 22, 2010 – CE mark certification was granted this week for the BMEYE ccNexfin, the first noninvasive cardiovascular monitor with Masimo Rainbow SET Pulse CO-Oximetry technology.
The devices combines two noninvasive technologies, the BMEYE for cardiovascular monitoring and Masimo Rainbow SET for hemoglobin and oxygen saturation monitoring. It provides real-time, beat-to-beat measurements of cardiac, circulatory, and pulmonary parameters, which may enable clinicians to detect impending cardiovascular crisis before organ injury ensues.
The ccNexfin utilizes a single sensor finger cuff (BMEYE) and finger sensor (Masimo Rainbow SET). The sensors capture and continuously measure beat-to-beat blood pressure (sys/dia), mean arterial pressure (MAP), cardiac output (CO), stroke volume (SV), systemic vascular resistance (SVR), derivative of pressure (dP/dt), noninvasive hemoglobin (SpHb), oxygen saturation (SpO2), and perfusion index (PI). This data allows clinicians to predict and proactively address the early signs of hemodynamic instability during critical situations rather than reacting to late indicators and their effects.
Hemodynamic monitoring has traditionally relied upon invasive, costly, or intermittent methods to assist clinicians in maintaining adequate oxygen delivery and tissue perfusion to prevent hypoxia and its irreversible damage. The integration of ccNexfin and Masimo Rainbow SET technologies into the emergency department, intensive care units, and anesthesiology care areas has the potential to facilitate earlier diagnosis.
For more information: www.masimo.com